08048035996
Ramiven 100 mg Tablet UK Wholesale – Leeds | Competitive Prices | Phoenix Exim | Trusted Exporter

1. General Information

Ramiven 100 mg Tablet is an oral targeted anticancer medicine containing Abemaciclib 100 mg. It is manufactured/marketed by Eli Lilly and Company India Pvt. Ltd. in India. The medicine is available as a prescription product and should be used under the supervision of an oncologist or other qualified healthcare professional.

Unlike traditional chemotherapy, Abemaciclib specifically targets proteins involved in cancer-cell division. It is commonly used as part of a treatment regimen for HR-positive, HER2-negative breast cancer.

2. Product Information

ProductRamiven 100 mg Tablet
Active IngredientAbemaciclib
Strength100 mg
Dosage FormOral tablet
Drug ClassAnticancer / CDK4/6 inhibitor
Therapeutic AreaOncology
Main IndicationCertain HR-positive, HER2-negative breast cancers
PrescriptionRequired
Manufacturer/Marketer in IndiaEli Lilly and Company India Pvt. Ltd.

Ramiven 100 mg is available in tablet form, with commonly listed Indian packs containing 7 tablets.

3. Uses of Ramiven 100 mg

Ramiven 100 mg is used for certain forms of HR-positive, HER2-negative breast cancer, including:

  • Advanced or metastatic breast cancer.
  • Certain early-stage breast cancers with a high risk of recurrence.
  • Treatment in combination with endocrine therapies such as an aromatase inhibitor or fulvestrant, depending on the patient's treatment plan.
  • In selected situations, Abemaciclib may be prescribed as monotherapy after previous endocrine therapy.

The exact indication and combination depend on the patient's cancer characteristics and the oncologist's treatment plan.

4. Benefits of Ramiven 100 mg

The principal therapeutic benefit of Ramiven is its ability to slow the growth and division of certain breast cancer cells.

Potential treatment benefits include:

  • Helps control the progression of HR-positive, HER2-negative breast cancer.
  • Can delay cancer progression in appropriate patients.
  • Provides targeted inhibition of cancer-cell proliferation.
  • Can be combined with endocrine therapy for appropriate patients.
  • May help reduce the risk of recurrence in selected high-risk early breast cancer patients.

Treatment benefits vary from patient to patient and should be evaluated by the treating oncologist.

5. Side Effects of Ramiven 100 mg

Like other anticancer medicines, Ramiven may cause side effects. Some can be significant and require medical monitoring.

Possible adverse effects include:

  • Diarrhea
  • Nausea
  • Vomiting
  • Fatigue
  • Decreased appetite
  • Abdominal discomfort
  • Headache
  • Hair loss
  • Joint pain
  • Dizziness
  • Reduced white blood cell counts
  • Anemia
  • Increased liver enzymes
  • Increased creatinine
  • Infection

Neutropenia, or a reduction in neutrophils, is an important adverse effect because it can increase the risk of infection.

6. Common Side Effects

Frequently reported side effects include:

  1. Diarrhea
  2. Nausea
  3. Fatigue or tiredness
  4. Vomiting
  5. Abdominal pain
  6. Headache
  7. Reduced appetite
  8. Hair loss
  9. Joint pain
  10. Changes in blood-cell counts

Diarrhea can occur early during treatment and may require prompt management if severe or persistent.

7. How to Use Ramiven 100 mg

Ramiven should be taken exactly as prescribed by the oncologist.

  • Swallow the tablet whole with water.
  • It may generally be taken with or without food.
  • Do not crush, chew, or break the tablet unless specifically instructed by a healthcare professional.
  • Take doses at the prescribed times each day.
  • Do not change the dose or stop treatment without consulting the doctor.
  • If vomiting occurs after a dose, do not automatically take another tablet; follow the doctor's instructions.
  • Regular blood tests may be required during treatment.

The appropriate dose and treatment schedule depend on the patient's indication, other medicines, tolerability, and clinical condition.

8. How Ramiven 100 mg Works

Ramiven contains Abemaciclib, which inhibits cyclin-dependent kinases 4 and 6 (CDK4/6).

These proteins play an important role in cell-cycle progression and cell division. By blocking CDK4/6 activity, Abemaciclib can slow the progression of cancer cells through the cell cycle, thereby helping to slow cancer-cell multiplication and tumor progression.

9. Safety Advice

Ramiven is a prescription oncology medicine and should be used only under appropriate medical supervision.

Pregnancy: Abemaciclib may harm an unborn baby. Patients who are pregnant or planning pregnancy should discuss this with their doctor before treatment.

Breastfeeding: Breastfeeding is generally not recommended during treatment; discuss the appropriate approach with the treating physician.

Liver disease: Patients with liver problems may require additional monitoring or dose adjustment.

Kidney disease: Inform the physician about existing kidney problems before treatment.

Infections: Because treatment can reduce certain blood-cell counts, patients should report signs of infection promptly.

Drug interactions: Medicines such as carbamazepine, enzalutamide and certain other drugs can significantly affect Abemaciclib levels. Patients should provide their doctor with a complete list of medicines and supplements they use.

Grapefruit: Grapefruit and grapefruit juice may increase Abemaciclib exposure and should generally be avoided unless the treating physician advises otherwise.

10. Frequently Asked Questions

Q1. What is Ramiven 100 mg Tablet?
Ramiven 100 mg is an oral anticancer medicine containing Abemaciclib 100 mg, a CDK4/6 inhibitor.

Q2. What is Ramiven 100 mg used for?
It is used for certain HR-positive, HER2-negative breast cancers, including advanced/metastatic disease and selected early breast cancer cases.

Q3. Is Ramiven a chemotherapy medicine?
It is a targeted anticancer therapy rather than conventional cytotoxic chemotherapy. It works by inhibiting CDK4 and CDK6.

Q4. Can Ramiven be taken with food?
Yes. It can generally be taken with or without food, according to the prescribing doctor's instructions.

Q5. What are the common side effects?
Diarrhea, nausea, fatigue, vomiting, abdominal discomfort, headache, hair loss and changes in blood counts are among the reported effects.

Q6. Does Ramiven require a prescription?
Yes. It is a prescription anticancer medicine and should be used under medical supervision.

Q7. Should Ramiven be stopped if side effects occur?
Do not stop or alter treatment independently. Contact the treating oncologist, who can decide whether supportive treatment, dose modification or interruption is appropriate.

Q8. Can Ramiven be used during pregnancy?
It is not recommended during pregnancy because Abemaciclib may harm the developing fetus. Consult the treating physician regarding contraception and pregnancy planning.

11. Substitute for Ramiven 100 mg

Because Ramiven contains Abemaciclib 100 mg, potential substitutes should be considered based on the same active ingredient and strength, rather than simply choosing another breast-cancer medicine.

Other Abemaciclib strengths listed in India include 50 mg, 150 mg and 200 mg, but these are not automatically interchangeable with the 100 mg dose.

Other CDK4/6 inhibitors such as Palbociclib or Ribociclib are different medicines and should only be considered as alternatives by the treating oncologist.

Important: Do not substitute, change strength, or change anticancer therapy without a physician's prescription.

12. SEO & B2B Keywords

For Phoenix Exim, Nagpur, India, suitable informational/B2B keywords include:

  • Ramiven 100 mg Tablet supplier India
  • Ramiven 100 mg Tablet exporter from India
  • Ramiven 100 mg Abemaciclib supplier
  • Abemaciclib 100 mg Tablet exporter India
  • Abemaciclib 100 mg pharmaceutical supplier
  • Ramiven 100 mg Tablet wholesale supplier
  • Ramiven 100 mg Tablet international supplier
  • Ramiven 100 mg Tablet pharmaceutical exporter
  • Ramiven 100 mg Tablet supplier Nagpur
  • Abemaciclib medicine exporter from Nagpur
  • Abemaciclib oncology medicine supplier India
  • Ramiven 100 mg breast cancer medicine
  • HR positive HER2 negative breast cancer medicine
  • Abemaciclib CDK4/6 inhibitor supplier
  • Ramiven 100 mg oncology medicine exporter
  • Ramiven 100 mg Tablet supplier USA
  • Ramiven 100 mg Tablet supplier UK
  • Ramiven 100 mg Tablet supplier Australia
  • Ramiven 100 mg Tablet supplier Singapore
  • Ramiven 100 mg Tablet supplier Canada
  • Ramiven 100 mg Tablet supplier South Korea
  • Ramiven 100 mg Tablet supplier UAE
  • Abemaciclib 100 mg supplier USA
  • Abemaciclib 100 mg supplier UK
  • Abemaciclib 100 mg supplier Australia
  • Abemaciclib 100 mg supplier Canada
  • Abemaciclib 100 mg supplier UAE
  • Indian pharmaceutical exporter for oncology medicines
  • Phoenix Exim oncology medicine exporter
  • Phoenix Exim pharmaceutical supplier Nagpur India
Aug 12th, 2026 2:59 PM

Keywords